Categorization of Meibomian Gland Dysfunction Using Lipid Layer Thickness and Meibomian Gland Dropout in Dry Eye Patients: A Retrospective Study
- Author:
Phil Kyu LEE
1
;
Jae Lim CHUNG
;
Da Ran KIM
;
Young Chae YOON
;
SoonWon YANG
;
Woong-Joo WHANG
;
Yong-Soo BYUN
;
HyungBin HWANG
;
Kyung Sun NA
;
HyunSoo LEE
;
So Hyang CHUNG
;
Eun Chul KIM
;
YangKyung CHO
;
Hyun Seung KIM
;
Ho Sik HWANG
Author Information
- Publication Type:Original Article
- From:Korean Journal of Ophthalmology 2024;38(1):64-70
- CountryRepublic of Korea
- Language:EN
-
Abstract:
Purpose:In the present study, we determined the prevalence of obstructive meibomian gland dysfunction (MGD), hyposecretory MGD, grossly normal MG, and hypersecretory MGD in patients with dry eye syndrome using lipid layer thickness (LLT) and MG dropout.
Methods:Eighty-eight patients with dry eye syndrome were included in the study. Patients were categorized into four groups according to the LLT and weighted total meiboscore. The proportion of patients in each group was calculated. The age, sex, Ocular Surface Disease Index, LLT, Schirmer, tear film breakup time, cornea stain, weighted total meiboscore, expressibility, and quality of meibum were compared between the four groups.
Results:Fifteen eyes (17.0%) had obstructive MGD, two eyes (2.3%) had hyposecretory MGD, 40 eyes (45.5%) had grossly normal MG, and 17 eyes (19.3%) had hypersecretory MGD. The obstructive MGD group was younger than the grossly normal MG group. In obstructive MGD, the ratio of men to women was higher than that of the other groups. However, Ocular Surface Disease Index, Schirmer, tear film breakup time, and corneal stain did not show statistically significant differences between the four groups. The meibum expressibility of the hyposecretoy MGD group was worse than those of the other groups. The meibum expressibility of the hyposecretoy MGD group was poor than those of the obstructive and hypersecretory MGD group.
Conclusions:This categorization was expected to help determine the best treatment method for dry eye syndrome, according to the MG status.
